Report Highlights
Report Includes
- An examination of the growth of immunoassay technology in clinical, food safety, and environmental areas; this report focuses on immunoassays for drug screening
- Analysis of global market trends, with data provided for 2011 and 2012, and projections, with five-year compound annual growth rates (CAGRs), through 2017
- Discussion of government regulations and technology patents and the roles they play in development
- Analysis of new markets
- Comprehensive company profiles of major players.
INTRODUCTION
STUDY GOALS AND OBJECTIVES
BCC’s goal in conducting this study was to determine the current status of the worldwide demand for immunoassays and to assess its growth potential over the five-year period from 2012 to 2017. We were particularly interested in the key industry applications of immunoassay technology in the U.S., Europe, Africa, the Middle East, and Asia. In addition, we were interested in the market potential for key prevailing immunoassay technology applications. Our main objective was to present a comprehensive analysis of the current immunoassay technology markets and its future direction.
REASONS FOR DOING THIS STUDY
Immunoassays represent one of the most used testing methodologies in the world today. Hence, we were interested in determining the different immunoassay applications and examining their growth potential. We also were especially interested in determining the types of technologies currently in use and their specific applications.
BCC has over the past several years examined the biological technology industry. Within this period, Immunoassay technology used in various types of medical and other diagnostics-type applications has taken diverse configurations. As a consequence, the use of this technology is changing with time. Therefore, BCC wanted to conduct a thorough and detailed analysis of immunoassay technology and project its growth potential.
CONTRIBUTIONS TO THE STUDY AND FOR WHOM
We have compiled a study of current immunoassay testing procedures markets and new emerging immunoassay technology markets. We present the economic environment of the immunoassay examination industry, technological descriptions and issues, applications, market factors, and potential, and project growth trends for the period of year 2012 to 2017. We also project market values and the distribution of immunoassay testing applications by the major market segments. This study will be of interest to the medical laboratory, in vitro diagnostics, biotechnologies, medical diagnostic products, and drug testing industries. It will also be of interest to biological detection device hardware and software developers, manufacturing companies, and distributors.
SCOPE AND FORMAT
The scope of this study encompasses an investigation of the markets for the following immunoassay testing categories: enzyme, fluorescence, radio-immunoassay (RIA), cardiac analysis, infectious diseases, and tumor diagnosis. BCC analyzes each immunoassay examination type, determines its current market status, examines its impact on future markets, and presents forecasts of growth over the next five years. Technological issues including the latest trends are discussed. BCC analyzes the industry on a worldwide basis, both from an application and demand point of view in the major regions of the world.
METHODOLOGY
BCC presents an analysis of each diagnostic application type and its estimated demand in 2012. Our estimated values are based on how much buying entities can be expected to pay in un-depreciated dollars. We then analyzed the potential applications for each usage in the field of immunoassay testing, and forecast the market size for 2012 and 2017. We also analyzed the demand for immunoassay analysis by major geographical market segments. All tables and figures are calculated in 2012 constant U.S. dollars.
INFORMATION SOURCES
BCC analyzed data produced by U.S. government agencies, industry trade associations, and international organizations to obtain data for this study. We also spoke with manufacturers of various immunoassay technology types in the U.S., the European Union, and Japan. In addition, we compiled data from current financial and trade information sources.
BCC ONLINE SERVICES
BCC offers an online information retrieval service. BCC’s home page, located at www.bccresearch.com, enables readers to:
- Examine BCC’s complete catalog of market research reports and place direct orders.
- Subscribe to any of BCC’s many industry newsletters.
- Read announcements of recently published reports and newly launched newsletters.
- Register for BCC’s well-known conferences.
- Request additional information on any BCC product.
- Take advantage of special offers.
DISCLAIMER
The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal or accounting advice, nor should it serve as a corporate policy guide, laboratory manual or an endorsement of any product, as much of the information is of a speculative in nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or from its use.
Related Reports
Immunoassays: Technologies and Global Markets
The global immunoassay tests market reached $30.6 billion in 2022 and should reach $39.8 billion by 2027, with a compound annual growth rate (CAGR) of 5.4% during the forecast period of 2022-2027.
Antibody Drugs: Technologies and Global Markets
The global market for therapeutic monoclonal antibodies (mAbs) was estimated at $44.6 billion in 2011. With the rollout of at least eight new therapeutic mAb products and expanded indications for existing products expected during the forecast period, the global mAb market is expected to rise at a compound annual growth rate (CAGR) of 5.3% to nearly $58 billion in 2016.
Labeling and Linkage Agents for Immunoassays and Gene Probes
The market for immunoagents, probes and molecular diagnostics was $29.6 billion in 2010. This market is projected to be $33.5 billion in 2011 and will increase up to $60.3 billion by 2016 at a compound annual growth rate (CAGR) of 12.5%.
Cell-based Assays: Technologies and Global Markets
Cell biology is currently the biggest revenue contributor to the life-science tools industry, accounting for approximately 30% of total sales. It is expected to grow to a $15 billion market by 2015, increasing at a compound annual growth rate (CAGR) of 12.3% from its 2010 value of $8.5 billion.
Recent Reports
Artificial Intelligence (AI) in Cancer
The global market for artificial intelligence (AI) in cancer is estimated to increase from $2.2 billion in 2024 to reach $6.3 billion by 2029, at a compound annual growth rate (CAGR) of 23.1% from 2024 through 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Induced Pluripotent Stem Cells: Global Markets
The global market for induced pluripotent stem cells (iPSCs) is expected to grow from $3.4 billion in 2023 to reach $5.2 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.1% from 2023 to 2028.
Commercial Amino Acids
The global market for commercial amino acids was valued at $30.1 billion in 2023. It is expected to grow from $31.8 billion in 2024 to $42.8 billion by 2029, at a compound annual growth rate (CAGR) of 6.1% from 2024 through 2029.
Top Trending Reports
AI in Clinical and Molecular Diagnostics Market
The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Artificial Intelligence (AI) Market: Investments vs Potential
The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More